The Mycobacterium tuberculosis FAS-II condensing enzymes: Their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development

Apoorva Bhatt, Virginie Molle, Gurdyal S. Besra, William R. Jacobs, Laurent Kremer

Research output: Contribution to journalShort survey

128 Citations (Scopus)

Abstract

Mycolic acids are very long-chain fatty acids representing essential components of the mycobacterial cell wall. Considering their importance, characterization of key enzymes participating in mycolic acid biosynthesis not only allows an understanding of their role in the physiology of mycobacteria, but also might lead to the identification of new drug targets. Mycolates are synthesized by at least two discrete elongation systems, the type I and type II fatty acid synthases (FAS-I and FAS-II respectively). Among the FAS-II components, the condensing enzymes that catalyse the formation of carbon-carbon bonds have received considerable interest. Four condensases participate in initiation (mtFabH), elongation (KasA and KasB) and termination (Pks13) steps, leading to full-length mycolates. We present the recent biochemical and structural data for these important enzymes. Special emphasis is given to their role in growth, intracellular survival, biofilm formation, as well as in the physiopathology of tuberculosis. Recent studies demonstrated that phosphorylation of these enzymes by mycobacterial kinases affects their activities. We propose here a model in which kinases that sense environmental changes can phosphorylate the condensing enzymes, thus representing a novel mechanism of regulating mycolic acid biosynthesis. Finally, we discuss the attractiveness of these enzymes as valid targets for future antituberculosis drug development.

Original languageEnglish (US)
Pages (from-to)1442-1454
Number of pages13
JournalMolecular Microbiology
Volume64
Issue number6
DOIs
StatePublished - Jun 1 2007

Fingerprint

Mycolic Acids
Mycobacterium tuberculosis
Acids
Enzymes
Pharmaceutical Preparations
Type I Fatty Acid Synthase
Type II Fatty Acid Synthase
Phosphotransferases
Carbon
Glycogen Synthase
Essential Fatty Acids
Mycobacterium
Biofilms
Cell Wall
Tuberculosis
Phosphorylation
Growth

ASJC Scopus subject areas

  • Microbiology
  • Molecular Biology

Cite this

The Mycobacterium tuberculosis FAS-II condensing enzymes : Their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. / Bhatt, Apoorva; Molle, Virginie; Besra, Gurdyal S.; Jacobs, William R.; Kremer, Laurent.

In: Molecular Microbiology, Vol. 64, No. 6, 01.06.2007, p. 1442-1454.

Research output: Contribution to journalShort survey

@article{699cbe81ba7844c3a37c2cf483c0780e,
title = "The Mycobacterium tuberculosis FAS-II condensing enzymes: Their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development",
abstract = "Mycolic acids are very long-chain fatty acids representing essential components of the mycobacterial cell wall. Considering their importance, characterization of key enzymes participating in mycolic acid biosynthesis not only allows an understanding of their role in the physiology of mycobacteria, but also might lead to the identification of new drug targets. Mycolates are synthesized by at least two discrete elongation systems, the type I and type II fatty acid synthases (FAS-I and FAS-II respectively). Among the FAS-II components, the condensing enzymes that catalyse the formation of carbon-carbon bonds have received considerable interest. Four condensases participate in initiation (mtFabH), elongation (KasA and KasB) and termination (Pks13) steps, leading to full-length mycolates. We present the recent biochemical and structural data for these important enzymes. Special emphasis is given to their role in growth, intracellular survival, biofilm formation, as well as in the physiopathology of tuberculosis. Recent studies demonstrated that phosphorylation of these enzymes by mycobacterial kinases affects their activities. We propose here a model in which kinases that sense environmental changes can phosphorylate the condensing enzymes, thus representing a novel mechanism of regulating mycolic acid biosynthesis. Finally, we discuss the attractiveness of these enzymes as valid targets for future antituberculosis drug development.",
author = "Apoorva Bhatt and Virginie Molle and Besra, {Gurdyal S.} and Jacobs, {William R.} and Laurent Kremer",
year = "2007",
month = "6",
day = "1",
doi = "10.1111/j.1365-2958.2007.05761.x",
language = "English (US)",
volume = "64",
pages = "1442--1454",
journal = "Molecular Microbiology",
issn = "0950-382X",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The Mycobacterium tuberculosis FAS-II condensing enzymes

T2 - Their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development

AU - Bhatt, Apoorva

AU - Molle, Virginie

AU - Besra, Gurdyal S.

AU - Jacobs, William R.

AU - Kremer, Laurent

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Mycolic acids are very long-chain fatty acids representing essential components of the mycobacterial cell wall. Considering their importance, characterization of key enzymes participating in mycolic acid biosynthesis not only allows an understanding of their role in the physiology of mycobacteria, but also might lead to the identification of new drug targets. Mycolates are synthesized by at least two discrete elongation systems, the type I and type II fatty acid synthases (FAS-I and FAS-II respectively). Among the FAS-II components, the condensing enzymes that catalyse the formation of carbon-carbon bonds have received considerable interest. Four condensases participate in initiation (mtFabH), elongation (KasA and KasB) and termination (Pks13) steps, leading to full-length mycolates. We present the recent biochemical and structural data for these important enzymes. Special emphasis is given to their role in growth, intracellular survival, biofilm formation, as well as in the physiopathology of tuberculosis. Recent studies demonstrated that phosphorylation of these enzymes by mycobacterial kinases affects their activities. We propose here a model in which kinases that sense environmental changes can phosphorylate the condensing enzymes, thus representing a novel mechanism of regulating mycolic acid biosynthesis. Finally, we discuss the attractiveness of these enzymes as valid targets for future antituberculosis drug development.

AB - Mycolic acids are very long-chain fatty acids representing essential components of the mycobacterial cell wall. Considering their importance, characterization of key enzymes participating in mycolic acid biosynthesis not only allows an understanding of their role in the physiology of mycobacteria, but also might lead to the identification of new drug targets. Mycolates are synthesized by at least two discrete elongation systems, the type I and type II fatty acid synthases (FAS-I and FAS-II respectively). Among the FAS-II components, the condensing enzymes that catalyse the formation of carbon-carbon bonds have received considerable interest. Four condensases participate in initiation (mtFabH), elongation (KasA and KasB) and termination (Pks13) steps, leading to full-length mycolates. We present the recent biochemical and structural data for these important enzymes. Special emphasis is given to their role in growth, intracellular survival, biofilm formation, as well as in the physiopathology of tuberculosis. Recent studies demonstrated that phosphorylation of these enzymes by mycobacterial kinases affects their activities. We propose here a model in which kinases that sense environmental changes can phosphorylate the condensing enzymes, thus representing a novel mechanism of regulating mycolic acid biosynthesis. Finally, we discuss the attractiveness of these enzymes as valid targets for future antituberculosis drug development.

UR - http://www.scopus.com/inward/record.url?scp=34250198660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250198660&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2958.2007.05761.x

DO - 10.1111/j.1365-2958.2007.05761.x

M3 - Short survey

C2 - 17555433

AN - SCOPUS:34250198660

VL - 64

SP - 1442

EP - 1454

JO - Molecular Microbiology

JF - Molecular Microbiology

SN - 0950-382X

IS - 6

ER -